Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

26/03/2014 New companies in the UAB Research Park 18/03/2014 The public-private partnership ESTEVE-UAB is bearing fruit 11/03/2014 Barcelona ranked fourth place among the most attractive European cities for investors 24/02/2014 Zero2infinity offers sightseeing flights in the stratosphere 18/02/2014 Students from Harvard visited the Barcelona Synchrotron Park and ALBA 11/02/2014 Applications of the Alba synchrotron in the materials and chemistry industries
42 43 44 45 46 47 48 49